Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Price Target at $6.63

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) have received an average recommendation of “Hold” from the nine brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and three have given a buy recommendation to the company. […]

Leave a Reply

Your email address will not be published.

Previous post Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $98.14
Next post Bank OZK (NASDAQ:OZK) Receives $49.13 Consensus Price Target from Analysts